Monitoring Monoclonal Antibody Delivery in Oncology: The Example of Bevacizumab

Open Access

Peer-reviewed

Research Article

Guillaume Nugue,

Affiliations Grenoble Institut des Neurosciences, Grenoble, France, Université Joseph Fourier, Grenoble, France
⨯
Marie Bidart,

Affiliations Grenoble Institut des Neurosciences, Grenoble, France, Centre Hospitalier Universitaire, Grenoble, France, Université Joseph Fourier, Grenoble, France
⨯
Marie Arlotto,

Affiliations Grenoble Institut des Neurosciences, Grenoble, France, Université Joseph Fourier, Grenoble, France
⨯
Mireille Mousseau,

Affiliations Grenoble Institut des Neurosciences, Grenoble, France, Centre Hospitalier Universitaire, Grenoble, France, Université Joseph Fourier, Grenoble, France
⨯
François Berger,

Affiliations Grenoble Institut des Neurosciences, Grenoble, France, Centre Hospitalier Universitaire, Grenoble, France, Université Joseph Fourier, Grenoble, France
⨯
Laurent Pelletier

* E-mail: laurent.pelletier@ujf-grenoble.fr

Affiliations Grenoble Institut des Neurosciences, Grenoble, France, Centre Hospitalier Universitaire, Grenoble, France, Université Joseph Fourier, Grenoble, France
⨯

Reader Comments (0)

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Glioma
Is the Subject Area "Glioma" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Monoclonal antibodies
Is the Subject Area "Monoclonal antibodies" applicable to this article?

Thanks for your feedback.
Antibody therapy
Is the Subject Area "Antibody therapy" applicable to this article?

Thanks for your feedback.
Angiogenesis
Is the Subject Area "Angiogenesis" applicable to this article?

Thanks for your feedback.
Blood
Is the Subject Area "Blood" applicable to this article?

Thanks for your feedback.
Pharmacodynamics
Is the Subject Area "Pharmacodynamics" applicable to this article?

Thanks for your feedback.